Skip to main content

VIROLOGIC OUTCOMES OF LAMIVUDINE/DOLUTEGRAVIR IN VIROLOGICALLY SUPPRESSED SUBJECTS WITH EXPECTED OR CONFIRMED RESISTANCE TO LAMIVUDINE

  • ACRONYM: VOLVER
  • FSG CODE: GESIDA 11820
  • COORDINATOR: JOSÉ RAMÓN ARRIBAS LÓPEZ / FEDERICO PULIDO
  • COORDINATOR’S HOSPITAL: HOSPITAL UNIVERSITARIO LA PAZ, MADRID / HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, MADRID 
  • APPROVAL DATE: 22-JUL.-2020
  • PROTOCOL STATUS: ANALYZING DATA / PUBLISHED 
  • CEIC-S APPROVAL: YES
  • AEMYPS APPROVAL: YES
  • ENROLED PATIENTS: 121
  • TOTAL NUMBER OF PATIENTS TO INCLUDE: 120
  • SCIENTIFIC OUTPUT: PUBLISHED